PubMed=18772565; DOI=10.1292/jvms.70.853
Shibata S., Maeda S., Tsuchida H., Fukata T.
Phenotypic analysis for a cell line of canine epidermal keratinocytes.
J. Vet. Med. Sci. 70:853-855(2008)

PubMed=20837364; DOI=10.1016/j.vetimm.2010.08.008
Shibata S., Maeda S., Kondo N., Chimura N., Inoue A., Fukata T.
Identification of the signaling pathway of TNF-alpha-induced CCL17/TARC transcription in a canine keratinocyte cell line.
Vet. Immunol. Immunopathol. 139:90-98(2011)

PubMed=20860556; DOI=10.1111/j.1365-3164.2010.00897.x
Shibata S., Maeda S., Kondo N., Inoue A., Maeda S., Chimura N., Fukata T.
Effect of recombinant canine interferon-gamma on granulocyte-macrophage colony-stimulating factor, transforming growth factor-beta and CC chemokine ligand 17 mRNA transcription in a canine keratinocyte cell line (CPEK).
Vet. Dermatol. 22:24-30(2011)

PubMed=23067725; DOI=10.1016/j.vetmic.2012.09.017
Mullin J., Carter S., Williams N., McEwan N., Nuttall T.
Transcription of canine Toll-like receptor 2, beta-defensin 1 and beta-defensin 103 in infected atopic skin, non-infected atopic skin, healthy skin and the CPEK cell line.
Vet. Microbiol. 162:700-706(2013)

PubMed=25190452; DOI=10.1186/s12917-014-0184-9; PMCID=PMC4172958
Pang L.Y., Argyle S.A., Kamida A., Morrison K.O., Argyle D.J.
The long-acting COX-2 inhibitor mavacoxib (Trocoxil TM) has anti-proliferative and pro-apoptotic effects on canine cancer cell lines and cancer stem cells in vitro.
BMC Vet. Res. 10:184.1-184.11(2014)

PubMed=30268330; DOI=10.1016/j.tvjl.2018.09.001
Miyamoto R., Kurita S., Tani H., Ikeda T., Ishizaka M., Saima H., Kobayashi M., Tamura K., Bonkobara M.
Canine squamous cell carcinoma cell lines with high expression of survivin are sensitive to survivin inhibitor YM155.
Vet. J. 240:31-36(2018)